Abstract:The G protein-coupled receptor (GPCR) TAS2R38 is a bitter taste receptor that can respond to bitter compounds such as phenylthiocarbamide (PTC) and 6-n-propylthiouracil (PROP). This receptor was chosen because its four haplotypes (based on three residue site polymorphism) hTAS2R38(PAV), hTAS2R38(AVI), hTAS2R38(AAI), and hTAS2R38(PVV) are known to have dramatically different responses to PTC and PROP. We aimed to identify the protein ligand interaction features that determine whether the bitter taste signal from this receptor is sent to the cortex. To do this we predicted the 3D structures of the TAS2R38 bitter taste receptor using our new BiHelix and SuperBiHelix Monte Carlo methods (No experimental determinations of the 3D structure have been reported for any taste receptors.). We find that residue 262 (2nd position in the polymorphism) is involved in the interhelical hydrogen bond network stabilizing the GPCR structure in tasters (hTAS2R38(PAV), hTAS2R38(AAI), and hTAS2R38(PVV)), while it is not in the nontaster (hTAS2R38(AVI)). This suggests that the hydrogen bond interactions between TM3 and TM6 or between TM5 and TM6 may play a role in activating this GPCR To further validate these structures, we used the DarwinDock method to predict the binding sites and 3D structures for PTC and PROP bound to hTAS2R38(PAV), hTAS2R38(AVI), hTAS2R38(AAI), and hTAS2R38(PVV), respectively. Our results show that PTC and PROP can form H-bonds with the backbone of residue 262 in the tasters (hTAS2R38pAv, hTAS2R38(AAI), and hTAS2R38(PVV)) but not in the nontaster (hTAS2R38(AVI)). Thus it appears that the hydrogen bond interaction between TM3 and TM6 may activate the receptor to pass the ligand binding signal to intracellular processes and that the H-bond between agonists and residue 262 in tasters is involved in the bitter tasting. This is in agreement with experimental observations, providing validation of the predicted ligand-protein complexes and also a potential activation mechanism for the TAS2R38 receptor.

Insight into the Interaction of Humulus lupulus L. Specialized Metabolites and Gastrointestinal Bitter Taste Receptors: In Vitro Study in STC-1 Cells and Molecular Docking

Humulus lupulus L.: Evaluation of Phytochemical Profile and Activation of Bitter Taste Receptors to Regulate Appetite and Satiety in Intestinal Secretin Tumor Cell Line (STC-1 Cells)

Identification of novel compounds for human bitter taste receptors.

Bitter taste TAS2R14 activation by intracellular tastants and cholesterol

Identification of Oncorhynchus Mykiss Nebulin-Derived Peptides As Bitter Taste Receptor TAS2R14 Blockers by in Silico Screening and Molecular Docking.

Structural basis for bitter taste receptor activation and its potential role in targeting diabetes

Analysis of the Expression of Human Bitter Taste Receptors in Extraoral Tissues

Computational Studies of Ligand-Receptor Interactions in Bitter Taste Receptors

Bitter taste receptors as sensors of gut luminal contents

Discovery of the Relationship Between Bitter Taste and Bitter Flavor (efficacy) Based on Htas2rs

Coarse-grained/molecular mechanics of the TAS2R38 bitter taste receptor: experimentally-validated detailed structural prediction of agonist binding

Unlocking TAS2R14 activation through intricate multi-ligand binding networks

Diet-induced regulation of bitter taste receptor subtypes in the mouse gastrointestinal tract

Bitter taste receptors along the gastrointestinal tract: comparison between humans and rodents

3D structure prediction of TAS2R38 bitter receptors bound to agonists phenylthiocarbamide (PTC) and 6-n-propylthiouracil (PROP).

A bitter pill for type 2 diabetes? The activation of bitter taste receptor TAS2R38 can stimulate GLP-1 release from enteroendocrine L-cells.

Pharmacological significance of extra-oral taste receptors

Intracellular binding pocket revealed in the human bitter taste receptor TAS2R14

The Predicted 3D Structure of Bitter Taste Receptors, TAS2R38 Based on a BiHelix and SuperBiHelix Methodologies

The Hidden One: What We Know About Bitter Taste Receptor 39

Reducing the Bitter Taste of Pharmaceuticals Using Cell-Based Identification of Bitter-Masking Compounds